anonymous
Guest
anonymous
Guest
Teva pharma receives a booster shot with FDA's approval for its generic version of EpiPen and EpiPen Jr. This will end the monopoly of Mylan. Also, Teva and Regeneron announce positive Phase 3 Fasinumab results in patients with chronic pain from osteoarthritis
https://news.alphastreet.com/teva-pharmaceuticals-fda-approval-epipen-generic/
https://news.alphastreet.com/teva-pharmaceuticals-fda-approval-epipen-generic/